Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HDAC9 antisense RNA 1 (HDAC9-AS1) is a long noncoding RNA transcript located on the antisense strand of the HDAC9 gene locus. Long noncoding RNAs such as HDAC9-AS1 can regulate gene expression through mechanisms such as chromatin remodeling, transcriptional interference, or epigenetic modification, but HDAC9-AS1 itself is not a protein-coding gene and is not a canonical therapeutic target. The search results do not provide experimentally validated functions, disease roles, or drug interactions for HDAC9-AS1. Most available molecular, functional, and therapeutic information pertains to the protein-coding gene HDAC9, not HDAC9-AS1[1][2][3]. There is a significant risk of confusion between HDAC9 (a class IIa histone deacetylase enzyme and validated therapeutic target) and HDAC9-AS1 (a noncoding RNA with unclear canonical roles). The information above should not be used to annotate a protein, receptor, or classic drug target for HDAC9-AS1 based on the available search results.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HDAC9 antisense RNA 1 (HDAC9-AS1).